Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia

NCT05696522 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT05696522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05696522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2023
Completion date
May 2, 2026
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, radiotherapy; complications, structural heart abnormality, ventricular tachycardia